» Articles » PMID: 24980874

Phosphatidylethanolamine Biomimetic Coating Increases Mesenchymal Stem Cell Osteoblastogenesis

Overview
Publisher Springer
Date 2014 Jul 2
PMID 24980874
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Previous observations (e.g., decreased bacterial adhesion) have shed the light on the auspicious possibility to use phosphatidylethanolamine as biomimetic coating for metal implants. Additionally, it was experimentally shown that phosphatidylethanolamine induces bone formation, however, up to now no study was performed to understand this observation or to find an explanation. In an attempt to unveil how and why phosphatidylethanolamine can improve cell metabolism and osteogenic differentiation, primary cells (human umbilical cord perivascular cells) were cultured on native or phosphatidylethanolamine coated surfaces. Several parameters were followed on gene (real time polymerase chain reaction) and protein (e.g., dot-blot and ELISA tests) levels. It was determined that phosphatidylethanolamine potentiates cell metabolism, osteogenic differentiation, and mineralisation early processes. By preventing biofilm formation while promoting new bone formation, phosphatidylethanolamine could be easily implemented as implant bio-mimicking coating.

Citing Articles

The Deposition of Hydroxyapatite Particles Within an Organic Matrix on the Surface of Poly(lactic acid).

Dopierala K, Krok E, Stachowska E, Nowak-Grzebyta J, Walczak K, Andrzejewski J Int J Mol Sci. 2024; 25(21).

PMID: 39519151 PMC: 11546348. DOI: 10.3390/ijms252111587.


Mendelian Randomization Study of Lipid Metabolites Reveals Causal Associations with Heel Bone Mineral Density.

Wu M, Du Y, Zhang C, Li Z, Li Q, Qi E Nutrients. 2023; 15(19).

PMID: 37836445 PMC: 10574167. DOI: 10.3390/nu15194160.


Endo- and Exometabolome Crosstalk in Mesenchymal Stem Cells Undergoing Osteogenic Differentiation.

Bispo D, Michalkova L, Correia M, Jesus C, Duarte I, Goodfellow B Cells. 2022; 11(8).

PMID: 35455937 PMC: 9024772. DOI: 10.3390/cells11081257.


Cobalt Chromium Molybdenum Surface Modifications Alter the Osteogenic Differentiation Potential of Human Mesenchymal Stem Cells.

Lohberger B, Eck N, Glaenzer D, Lichtenegger H, Ploszczanski L, Leithner A Materials (Basel). 2020; 13(19).

PMID: 32992906 PMC: 7579014. DOI: 10.3390/ma13194292.


Engineering microdent structures of bone implant surfaces to enhance osteogenic activity in MSCs.

Li S, Chow T, Chu J Biochem Biophys Rep. 2017; 9:100-105.

PMID: 29114582 PMC: 5632706. DOI: 10.1016/j.bbrep.2016.11.016.

References
1.
Schlegel R, Williamson P . Phosphatidylserine, a death knell. Cell Death Differ. 2001; 8(6):551-63. DOI: 10.1038/sj.cdd.4400817. View

2.
van Tuyl L, Voskuyl A, Boers M, Geusens P, Landewe R, Dijkmans B . Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis. Ann Rheum Dis. 2010; 69(9):1623-8. DOI: 10.1136/ard.2009.121764. View

3.
Santin M, Rhys-Williams W, OReilly J, Davies M, Shakesheff K, Love W . Calcium-binding phospholipids as a coating material for implant osteointegration. J R Soc Interface. 2006; 3(7):277-81. PMC: 1578739. DOI: 10.1098/rsif.2005.0088. View

4.
Willumeit R, Schossig M, Clemens H, Feyerabend F . In-vitro interactions of human chondrocytes and mesenchymal stem cells, and of mouse macrophages with phospholipid-covered metallic implant materials. Eur Cell Mater. 2007; 13:11-25. DOI: 10.22203/ecm.v013a02. View

5.
Takuwa Y, Ohse C, Wang E, Wozney J, Yamashita K . Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem Biophys Res Commun. 1991; 174(1):96-101. DOI: 10.1016/0006-291x(91)90490-x. View